BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17127487)

  • 1. Lack of association between gene sequence variations of platelet membrane receptors and aspirin responsiveness detected by the PFA-100 system in patients with coronary artery disease.
    Bernardo E; Angiolillo DJ; Ramírez C; Cavallari U; Trabetti E; Sabaté M; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Pignatti PF; Macaya C; Fernandez-Ortiz A
    Platelets; 2006 Dec; 17(8):586-90. PubMed ID: 17127487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association between aspirin responsiveness and seven candidate gene haplotypes in patients with symptomatic vascular disease.
    Kunicki TJ; Williams SA; Nugent DJ; Harrison P; Segal HC; Syed A; Rothwell PM
    Thromb Haemost; 2009 Jan; 101(1):123-33. PubMed ID: 19132198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of COX-1 and GPVI associate with the antiplatelet effect of aspirin in coronary artery disease patients.
    Lepäntalo A; Mikkelsson J; Reséndiz JC; Viiri L; Backman JT; Kankuri E; Karhunen PJ; Lassila R
    Thromb Haemost; 2006 Feb; 95(2):253-9. PubMed ID: 16493486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The GPIIIa PlA polymorphism and the platelet hyperactivity in Tunisian patients with stable coronary artery disease treated with aspirin.
    Abderrazek F; Chakroun T; Addad F; Dridi Z; Gerotziafas G; Gamra H; Hassine M; Elalamy I
    Thromb Res; 2010 Jun; 125(6):e265-8. PubMed ID: 20138334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for aspirin resistance in stable coronary artery patients by three different tests.
    Chakroun T; Addad F; Abderazek F; Ben-Farhat M; Hamdi S; Gamra H; Hassine M; Ben-Hamda K; Samama MM; Elalamy I
    Thromb Res; 2007; 121(3):413-8. PubMed ID: 17553552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin-resistant platelet aggregation in a cohort of patients with coronary heart disease.
    Pamukcu B; Oflaz H; Onur I; Oncul A; Umman B; Koylan N; Bugra Z; Meric M; Nisanci Y
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):461-5. PubMed ID: 17581321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of genetic polymorphisms on platelet function and aspirin resistance.
    Pamukcu B; Oflaz H; Onur I; Hancer V; Yavuz S; Nisanci Y
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):53-6. PubMed ID: 19923980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association between the 807 C/T polymorphism of glycoprotein Ia gene and post-treatment platelet reactivity after aspirin and clopidogrel in patients with acute coronary syndrome.
    Cuisset T; Frere C; Quilici J; Morange PE; Saut N; Romero-Barra M; Camoin L; Lambert M; Juhan-Vague I; Bonnet JL; Alessi MC
    Thromb Haemost; 2007 Feb; 97(2):212-7. PubMed ID: 17264949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of non-response to aspirin in patients with peripheral arterial occlusive disease during long-term follow-up.
    Linnemann B; Prochnow S; Mani H; Schwonberg J; Lindhoff-Last E
    Ann Hematol; 2009 Oct; 88(10):979-88. PubMed ID: 19247655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using the Platelet Function Analyzer-100 for monitoring aspirin therapy.
    Poulsen TS; Mickley H; Korsholm L; Licht PB; Haghfelt T; Jørgensen B
    Thromb Res; 2007; 120(2):161-72. PubMed ID: 17052745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring aspirin therapy with the Platelet Function Analyzer-100.
    Mortensen J; Poulsen TS; Grove EL; Refsgaard J; Nielsen HL; Pedersen SB; Thygesen SS; Hvas AM; Kristensen SD
    Scand J Clin Lab Invest; 2008; 68(8):786-92. PubMed ID: 18651324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet polymorphisms: frequency distribution and association with coronary artery disease in an Indian population.
    Ashavaid TF; Todur SP; Kondkar AA; Nair KG; Shalia KK; Dalal JJ; Rajani R; Ponde CK
    Platelets; 2011; 22(2):85-91. PubMed ID: 21034162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased basal platelet activity, plasma adiponectin levels, and diabetes mellitus are associated with poor platelet responsiveness to in vitro effect of aspirin.
    Takahashi S; Ushida M; Komine R; Shimizu A; Uchida T; Ishihara H; Shibano T; Watanabe G; Ikeda Y; Murata M
    Thromb Res; 2007; 119(4):517-24. PubMed ID: 16793119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke and aspirin non-responder patients: relation with hypertension and platelet response to adenosine diphosphate.
    Godeneche G; Sorel N; Ragot S; Chomel JC; Neau JP; Macchi L
    Platelets; 2009 Nov; 20(7):471-7. PubMed ID: 19852685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new definition of aspirin non-responsiveness by platelet function analyzer-100 and its predictors.
    Abaci A; Caliskan M; Bayram F; Yilmaz Y; Cetin M; Unal A; Cetin S
    Platelets; 2006 Feb; 17(1):7-13. PubMed ID: 16308181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring aspirin treatment in patients with thrombocytosis: comparison of the platelet function analyzer (PFA)-100 with optical aggregometry.
    Tsantes AE; Mantzios G; Giannopoulou V; Tsirigotis P; Bonovas S; Rapti E; Mygiaki E; Kartasis Z; Sitaras NM; Dervenoulas J; Travlou A
    Thromb Res; 2008; 123(1):100-7. PubMed ID: 18430462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of intravenous aspirin administration on platelet aspirin resistance after on-pump coronary artery bypass surgery.
    Bach J; Kammerer I; Isgro F; Haubelt H; Vogt A; Saggau W; Hellstern P
    Platelets; 2009 May; 20(3):150-7. PubMed ID: 19437331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene sequence variations of the platelet P2Y12 receptor are associated with coronary artery disease.
    Cavallari U; Trabetti E; Malerba G; Biscuola M; Girelli D; Olivieri O; Martinelli N; Angiolillo DJ; Corrocher R; Pignatti PF
    BMC Med Genet; 2007 Sep; 8():59. PubMed ID: 17803810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet hyperreactivity after coronary artery bypass grafting: the possible relevance to glycoprotein polymorphisms. A preliminary report.
    Golanski J; Golanski R; Chizynski K; Iwaszkiewicz A; Rozalski M; Wieclawska B; Boncler M; Watala C
    Platelets; 2001 Jun; 12(4):241-7. PubMed ID: 11454259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.